ANN SAMUELS: Open Payments
NPI 1295056729 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 22 payments from 12 companies in 2025. Trend: 2023 $912 · 2024 $1,086 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 4 | $119 |
| Novo Nordisk Inc | 5 | $106 |
| Ardelyx, Inc. | 1 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Calliditas Therapeutics US Inc. | 1 | $29 |
| Vifor Pharma, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: ACTHAR, XPHOZAH 30 MG, Ozempic, Kerendia, JARDIANCE, KRYSTEXXA, PURIFIED CORTROPHIN GEL, TARPEYO.
Industry payments across FL — which companies pay providers there.
